156 related articles for article (PubMed ID: 26073245)
1. Mediastinal Yolk Sac Tumor Producing Protein Induced by Vitamin K Absence or Antagonist-II.
Akutsu N; Adachi Y; Isosaka M; Mita H; Takagi H; Sasaki S; Yamamoto H; Arimura Y; Ishii Y; Masumori N; Endo T; Shinomura Y
Intern Med; 2015; 54(12):1531-6. PubMed ID: 26073245
[TBL] [Abstract][Full Text] [Related]
2. Protein induced by vitamin K absence or antagonist II (PIVKA-II) producing large cell neuroendocrine carcinoma (LCNEC) of lung with multiple liver metastases: A case report.
Kurohama H; Mihara Y; Izumi Y; Kamata M; Nagashima S; Komori A; Matsuoka Y; Ueki N; Nakashima M; Ito M
Pathol Int; 2017 Feb; 67(2):105-109. PubMed ID: 28075042
[TBL] [Abstract][Full Text] [Related]
3. Plasma abnormal prothrombin (PIVKA-II): a new and reliable marker for the detection of hepatocellular carcinoma.
Takikawa Y; Suzuki K; Yamazaki K; Goto T; Madarame T; Miura Y; Yoshida T; Kashiwabara T; Sato S
J Gastroenterol Hepatol; 1992; 7(1):1-6. PubMed ID: 1371940
[TBL] [Abstract][Full Text] [Related]
4. Acarboxy prothrombin (PIVKA-II) as a marker of hepatoblastoma in infants.
Motohara K; Endo F; Matsuda I; Iwamasa T
J Pediatr Gastroenterol Nutr; 1987; 6(1):42-5. PubMed ID: 2432210
[TBL] [Abstract][Full Text] [Related]
5. Abnormal prothrombin: evaluation as a tumour marker and localization in tissues of patients with hepatocellular carcinoma.
Koda T; Yamazaki S; Tamura I; Nakaba H; Takao T; Katayama S; Kurimura O
J Gastroenterol Hepatol; 1993; 8(3):212-6. PubMed ID: 7686054
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma].
Fujiyama S; Morishita T; Shibata J; Sato T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1129-38. PubMed ID: 2471453
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of plasma PIVKA-II as a new marker for hepatocellular carcinoma].
Tada H; Kagawa K; Hikita H; Takeuchi T; Ohta Y; Fukui S; Shintani H; Deguchi T; Okanoue T; Takino T
Gan No Rinsho; 1989 Apr; 35(5):564-70. PubMed ID: 2469809
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of serum alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels in patients with hepatocellular carcinoma following interventional radiology.
Minakuchi K; Murata K; Kaminoh T; Takada K; Takashima S; Nakamura K; Onoyama Y
Radiat Med; 1993; 11(6):231-6. PubMed ID: 7512271
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of PIVKA-II as a marker of hepatocellular carcinoma].
Arima K; Kodama T; Suga M; Sakamoto H; Ohe Y; Yachi A
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3049-52. PubMed ID: 2476968
[TBL] [Abstract][Full Text] [Related]
10. [Tumor markers of hepatocellular carcinoma].
Kubo S; Matsukawa M
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2203-6. PubMed ID: 15628773
[TBL] [Abstract][Full Text] [Related]
11. NX-PVKA levels before and after hepatectomy of hepatocellular carcinoma as predictors of patient survival: a preliminary evaluation of an improved assay for PIVKA-II.
Nanashima A; Abo T; Taura N; Shibata H; Ichikawa T; Takagi K; Arai J; Oyama S; Nagayasu T
Anticancer Res; 2013 Jun; 33(6):2689-97. PubMed ID: 23749928
[TBL] [Abstract][Full Text] [Related]
12. A resected case of metachronous liver metastasis from lung cancer producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II).
Oshiro Y; Takada Y; Enomoto T; Fukao K; Ishikawa S; Iijima T
Hepatogastroenterology; 2004; 51(58):1144-7. PubMed ID: 15239263
[TBL] [Abstract][Full Text] [Related]
13. Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
Nasu M; Soma T; Fukushima H; Kudo K; Matsubara O
Mod Pathol; 1997 Oct; 10(10):1054-8. PubMed ID: 9346187
[TBL] [Abstract][Full Text] [Related]
14. Des-gamma-carboxy prothrombin (PIVKA-II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation.
Hasegawa Y; Tomita K; Hashimoto K; Shigeoka Y; Watanabe M; Yamasaki A; Shimizu E
Anticancer Res; 2005; 25(6C):4569-71. PubMed ID: 16334143
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis.
Fan J; Chen Y; Zhang D; Yao J; Zhao Z; Jiang Y; Li Y; Guo Y
Surg Oncol; 2020 Sep; 34():245-255. PubMed ID: 32891338
[No Abstract] [Full Text] [Related]
16. [Tumor markers for hepatocellular carcinoma].
Tateishi R; Enooku K; Shiina S; Koike K
Nihon Rinsho; 2012 May; 70(5):821-7. PubMed ID: 22620007
[TBL] [Abstract][Full Text] [Related]
17. [Clinical signification and evaluation of PIVKA-II in hepatocellular carcinoma].
Matsushima A; Enomoto M; Yokoo Y; Arai M; Kobayashi T; Okuno F; Hirano Y; Sujita K; Eto S; Takagi T
Rinsho Byori; 1989 Jun; 37(6):683-6. PubMed ID: 2477568
[No Abstract] [Full Text] [Related]
18. [Early diagnosis of hepatocellular carcinoma by serum AFP and PIVKA-II analysis].
Aoyagi Y; Yanagi M; Asakura H
Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2003-7. PubMed ID: 8586921
[No Abstract] [Full Text] [Related]
19. Des-gamma carboxy prothrombin (PIVKA-II) and alpha-fetoprotein producing gastric cancer with multiple liver metastases.
Takahashi Y; Inoue T
Pathol Int; 2003 Apr; 53(4):236-40. PubMed ID: 12675768
[TBL] [Abstract][Full Text] [Related]
20. Abnormal prothrombin (PIVKA-II) and hepatocellular carcinoma.
Okuda H; Nakanish T; Furukawa M; Yamagata H; Obata H
Trop Gastroenterol; 1991; 12(2):59-66. PubMed ID: 1719681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
